| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOPSYCH.2017.10.020 |
| P8608 | Fatcat ID | release_xrvbmvqfhbh7li3yurhw7edlz4 |
| P698 | PubMed publication ID | 29174592 |
| P50 | author | Christine A. Denny | Q41138848 |
| Jean Claude Alvarez | Q57553174 | ||
| Antoine Defaix | Q80087936 | ||
| Thu Ha Pham | Q89257720 | ||
| P2093 | author name string | Alain M Gardier | |
| Donald W Landry | |||
| Shi-Xian Deng | |||
| Xiaoming Xu | |||
| Nicolas Fabresse | |||
| Rebecca A Brachman | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e3-e6 | |
| P577 | publication date | 2017-10-26 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects | |
| P478 | volume | 84 |
| Q88867740 | (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice |
| Q92339977 | (2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions |
| Q92878421 | (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism |
| Q92043421 | (R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism |
| Q90595239 | Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine |
| Q91843765 | Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function |
| Q55668935 | Author Correction: Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model. |
| Q52667723 | Convergent Mechanisms Underlying Rapid Antidepressant Action. |
| Q64111576 | Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter? |
| Q93177074 | Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments |
| Q60047223 | Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant? |
| Q55438088 | Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. |
| Q91600783 | Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression |
| Q89527723 | Ketamine: The final frontier or another depressing end? |
| Q53441048 | Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model. |
| Q52658612 | Mechanisms of ketamine action as an antidepressant. |
| Q94588755 | Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation |
| Q57293270 | Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants |
| Q91173369 | Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites |
| Q59760564 | Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine |
| Q92512363 | Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function |
| Q91575537 | Pharmaco-electroencephalographic responses in the rat differ between active and inactive locomotor states |
| Q92873306 | Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective |
| Q64098509 | Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine |
| Q94954574 | Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine |
| Q58213859 | The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects |
| Q56453443 | The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation? |
Search more.